Treatment objectives. Each GLP-1 agonist has certain approved makes use of and potential Advantages to assist you fulfill your treatment method aims.In Oct 2024, Novo Nordisk revealed a examine on scientific journal Nature a couple of novel glucose-sensitive insulin NNC2215 that could decrease the potential risk of hypoglycemia in animal versions.[